Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 23

1.

Genetic Variation Underpinning ADHD Risk in a Caribbean Community.

Puentes-Rozo PJ, Acosta-López JE, Cervantes-Henríquez ML, Martínez-Banfi ML, Mejia-Segura E, Sánchez-Rojas M, Anaya-Romero ME, Acosta-Hoyos A, García-Llinás GA, Mastronardi CA, Pineda DA, Castellanos FX, Arcos-Burgos M, Vélez JI.

Cells. 2019 Aug 16;8(8). pii: E907. doi: 10.3390/cells8080907.

2.

Experimental Models of Glaucoma: A Powerful Translational Tool for the Future Development of New Therapies for Glaucoma in Humans-A Review of the Literature.

Evangelho K, Mastronardi CA, de-la-Torre A.

Medicina (Kaunas). 2019 Jun 17;55(6). pii: E280. doi: 10.3390/medicina55060280. Review.

3.

Congenital Leptin Deficiency and Leptin Gene Missense Mutation Found in Two Colombian Sisters with Severe Obesity.

Yupanqui-Lozno H, Bastarrachea RA, Yupanqui-Velazco ME, Alvarez-Jaramillo M, Medina-Méndez E, Giraldo-Peña AP, Arias-Serrano A, Torres-Forero C, Garcia-Ordoñez AM, Mastronardi CA, Restrepo CM, Rodriguez-Ayala E, Nava-Gonzalez EJ, Arcos-Burgos M, Kent JW Jr, Cole SA, Licinio J, Celis-Regalado LG.

Genes (Basel). 2019 May 7;10(5). pii: E342. doi: 10.3390/genes10050342.

4.

Generation of one iPSC line (IMEDEAi006-A) from an early-onset familial Alzheimer's Disease (fAD) patient carrying the E280A mutation in the PSEN1 gene.

Vallejo-Diez S, Fleischer A, Martín-Fernández JM, Sánchez-Gilabert A, Castresana M, Aguillón D, Villegas A, Mastronardi CA, Espinosa LG, Arcos-Burgos M, Del Pozo Á, Herrán E, Gainza E, Isaza-Ruget M, Lopera F, Bachiller D.

Stem Cell Res. 2019 May;37:101440. doi: 10.1016/j.scr.2019.101440. Epub 2019 Apr 15.

5.

ADGRL3 (LPHN3) variants predict substance use disorder.

Arcos-Burgos M, Vélez JI, Martinez AF, Ribasés M, Ramos-Quiroga JA, Sánchez-Mora C, Richarte V, Roncero C, Cormand B, Fernández-Castillo N, Casas M, Lopera F, Pineda DA, Palacio JD, Acosta-López JE, Cervantes-Henriquez ML, Sánchez-Rojas MG, Puentes-Rozo PJ, Molina BSG; MTA Cooperative Group, Boden MT, Wallis D, Lidbury B, Newman S, Easteal S, Swanson J, Patel H, Volkow N, Acosta MT, Castellanos FX, de Leon J, Mastronardi CA, Muenke M.

Transl Psychiatry. 2019 Jan 29;9(1):42. doi: 10.1038/s41398-019-0396-7.

6.

Targeting Neuroplasticity, Cardiovascular, and Cognitive-Associated Genomic Variants in Familial Alzheimer's Disease.

Vélez JI, Lopera F, Creagh PK, Piñeros LB, Das D, Cervantes-Henríquez ML, Acosta-López JE, Isaza-Ruget MA, Espinosa LG, Easteal S, Quintero GA, Silva CT, Mastronardi CA, Arcos-Burgos M.

Mol Neurobiol. 2019 May;56(5):3235-3243. doi: 10.1007/s12035-018-1298-z. Epub 2018 Aug 15.

7.

Mutations modifying sporadic Alzheimer's disease age of onset.

Vélez JI, Lopera F, Patel HR, Johar AS, Cai Y, Rivera D, Tobón C, Villegas A, Sepulveda-Falla D, Lehmann SG, Easteal S, Mastronardi CA, Arcos-Burgos M.

Am J Med Genet B Neuropsychiatr Genet. 2016 Dec;171(8):1116-1130. doi: 10.1002/ajmg.b.32493. Epub 2016 Aug 30.

PMID:
27573710
8.

Role of the IL-1 Pathway in Dopaminergic Neurodegeneration and Decreased Voluntary Movement.

Stojakovic A, Paz-Filho G, Arcos-Burgos M, Licinio J, Wong ML, Mastronardi CA.

Mol Neurobiol. 2017 Aug;54(6):4486-4495. doi: 10.1007/s12035-016-9988-x. Epub 2016 Jun 29.

9.

Neural Plasticity in Obesity and Psychiatric Disorders.

Arcos-Burgos M, Acosta MT, Martinez AF, Muenke M, Enriori PJ, Mastronardi CA.

Neural Plast. 2016;2016:6053871. doi: 10.1155/2016/6053871. Epub 2016 Apr 7. No abstract available.

10.

A Mutation in DAOA Modifies the Age of Onset in PSEN1 E280A Alzheimer's Disease.

Vélez JI, Rivera D, Mastronardi CA, Patel HR, Tobón C, Villegas A, Cai Y, Easteal S, Lopera F, Arcos-Burgos M.

Neural Plast. 2016;2016:9760314. doi: 10.1155/2016/9760314. Epub 2016 Jan 5.

11.

Association between circulating adipocytokine concentrations and microvascular complications in patients with type 2 diabetes mellitus: A systematic review and meta-analysis of controlled cross-sectional studies.

Rodríguez AJ, Nunes Vdos S, Mastronardi CA, Neeman T, Paz-Filho GJ.

J Diabetes Complications. 2016 Mar;30(2):357-67. doi: 10.1016/j.jdiacomp.2015.11.004. Epub 2015 Nov 7. Review.

12.

New advances in the treatment of generalized lipodystrophy: role of metreleptin.

Rodriguez AJ, Mastronardi CA, Paz-Filho GJ.

Ther Clin Risk Manag. 2015 Sep 16;11:1391-400. doi: 10.2147/TCRM.S66521. eCollection 2015. Review.

13.

Periodontal Disease and Its Systemic Associated Diseases.

Fernandez-Solari J, Barrionuevo P, Mastronardi CA.

Mediators Inflamm. 2015;2015:153074. doi: 10.1155/2015/153074. Epub 2015 Aug 4. No abstract available.

14.

The use of dried blood spot sampling for the measurement of HbA1c: a cross-sectional study.

Mastronardi CA, Whittle B, Tunningley R, Neeman T, Paz-Filho G.

BMC Clin Pathol. 2015 Jul 8;15:13. doi: 10.1186/s12907-015-0013-5. eCollection 2015.

15.

Leptin replacement therapy for the treatment of non-HAART associated lipodystrophy syndromes: a meta-analysis into the effects of leptin on metabolic and hepatic endpoints.

Rodríguez AJ, Neeman T, Giles AG, Mastronardi CA, Paz Filho G.

Arq Bras Endocrinol Metabol. 2014 Nov;58(8):783-97. Epub 2014 Nov 1. Review.

PMID:
25465598
16.

Whole exome sequencing of extreme morbid obesity patients: translational implications for obesity and related disorders.

Paz-Filho G, Boguszewski MC, Mastronardi CA, Patel HR, Johar AS, Chuah A, Huttley GA, Boguszewski CL, Wong ML, Arcos-Burgos M, Licinio J.

Genes (Basel). 2014 Aug 25;5(3):709-25. doi: 10.3390/genes5030709.

17.

Leptin treatment: facts and expectations.

Paz-Filho G, Mastronardi CA, Licinio J.

Metabolism. 2015 Jan;64(1):146-56. doi: 10.1016/j.metabol.2014.07.014. Epub 2014 Aug 3. Review.

18.

Repeated antidepressant therapy increases cyclic GMP signaling in rat hippocampus.

Reierson GW, Mastronardi CA, Licinio J, Wong ML.

Neurosci Lett. 2009 Dec 11;466(3):149-53. doi: 10.1016/j.neulet.2009.09.047. Epub 2009 Sep 27.

19.

Chronic imipramine downregulates cyclic AMP signaling in rat hippocampus.

Reierson GW, Mastronardi CA, Licinio J, Wong ML.

Neuroreport. 2009 Feb 18;20(3):307-11.

PMID:
19444954
20.

Chronic fluoxetine treatment increases daytime melatonin synthesis in the rodent.

Reierson GW, Mastronardi CA, Licinio J, Wong ML.

Clin Pharmacol. 2009;1:1-6. doi: 10.2147/CPAA.S7157. Epub 2009 Sep 7.

Supplemental Content

Loading ...
Support Center